1. The prevalence of severe refractory asthma
Pieter-Paul W. Hekking, MD, Reinier R. Wener, MD, Marijke Amelink, MD, Aelko H. Zwinderman, PhD, Marcel L. Bouvy, MD, PhD, Elisabeth H. Bel, MD, PhD 
Journal of Allergy and Clinical Immunology 
Volume 135, Issue 4, Pages (April 2015)
DOI: /j.jaci
Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2. Fig 1
Study design: differentiating steps to get to a diagnosis of severe refractory asthma.
Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci )
Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3. Fig 2
Results. High-intensity treatment, high-dose ICS (≥1000 μg/d fluticasone equivalent) plus a LABA or medium- to high-dose ICS ( μg/d fluticasone equivalent) plus daily OCSs plus a prescription for a LABA.
Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci )
Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions